Metagenomi Therapeutics Inc
(MGX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 52,295 | 44,756 | 17,200 | 243 |
| Gross Profit | 52,295 | 44,756 | 17,200 | 243 |
| Operating Expenses | 141,196 | 123,248 | 61,840 | 24,190 |
| Operating Income | -88,901 | -78,492 | -44,640 | -23,947 |
| Interest Expense | 0 | 0 | 98 | 302 |
| Other Income | 5,330 | 18,264 | 3,714 | 2,807 |
| Pre-tax Income | -83,571 | -60,228 | -41,024 | -21,442 |
| Income Tax | -5,513 | 8,027 | 2,569 | N/A |
| Net Income Continuous | -78,058 | -68,255 | -43,593 | -21,442 |
| Net Income | $-78,058 | $-68,255 | $-43,593 | $-21,442 |
| EPS Basic Total Ops | -2.36 | -20.05 | -12.82 | -6.58 |
| EPS Basic Continuous Ops | -2.36 | -20.05 | -12.82 | -6.58 |
| EPS Diluted Total Ops | -2.36 | -20.05 | -12.82 | -6.58 |
| EPS Diluted Continuous Ops | -2.36 | -20.05 | -12.82 | -6.58 |
| EPS Diluted Before Non-Recurring Items | -2.30 | -20.05 | N/A | N/A |
| EBITDA(a) | $-91,323 | $-83,499 | $-44,350 | $-23,357 |